FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003622489> ?p ?o ?g. }

• W3003622489 endingPage "339" @default.
• W3003622489 startingPage "339" @default.
• W3003622489 abstract "Public health screening for type 1 diabetes in its presymptomatic stages may reduce disease severity and burden on a population level.To determine the prevalence of presymptomatic type 1 diabetes in children participating in a public health screening program for islet autoantibodies and the risk for progression to clinical diabetes.Screening for islet autoantibodies was offered to children aged 1.75 to 5.99 years in Bavaria, Germany, between 2015 and 2019 by primary care pediatricians during well-baby visits. Families of children with multiple islet autoantibodies (presymptomatic type 1 diabetes) were invited to participate in a program of diabetes education, metabolic staging, assessment of psychological stress associated with diagnosis, and prospective follow-up for progression to clinical diabetes until July 31, 2019.Measurement of islet autoantibodies.The primary outcome was presymptomatic type 1 diabetes, defined by 2 or more islet autoantibodies, with categorization into stages 1 (normoglycemia), 2 (dysglycemia), or 3 (clinical) type 1 diabetes. Secondary outcomes were the frequency of diabetic ketoacidosis and parental psychological stress, assessed by the Patient Health Questionnaire-9 (range, 0-27; higher scores indicate worse depression; ≤4 indicates no to minimal depression; >20 indicates severe depression).Of 90 632 children screened (median [interquartile range {IQR}] age, 3.1 [2.1-4.2] years; 48.5% girls), 280 (0.31%; 95% CI, 0.27-0.35) had presymptomatic type 1 diabetes, including 196 (0.22%) with stage 1, 17 (0.02%) with stage 2, 26 (0.03%) with stage 3, and 41 who were not staged. After a median (IQR) follow-up of 2.4 (1.0-3.2) years, another 36 children developed stage 3 type 1 diabetes. The 3-year cumulative risk for stage 3 type 1 diabetes in the 280 children with presymptomatic type 1 diabetes was 24.9% ([95% CI, 18.5%-30.7%]; 54 cases; annualized rate, 9.0%). Two children had diabetic ketoacidosis. Median (IQR) psychological stress scores were significantly increased at the time of metabolic staging in mothers of children with presymptomatic type 1 diabetes (3 [1-7]) compared with mothers of children without islet autoantibodies (2 [1-4]) (P = .002), but declined after 12 months of follow-up (2 [0-4]) (P < .001).Among children aged 2 to 5 years in Bavaria, Germany, a program of primary care-based screening showed an islet autoantibody prevalence of 0.31%. These findings may inform considerations of population-based screening of children for islet autoantibodies." @default.
• W3003622489 created "2020-02-07" @default.
• W3003622489 creator A5001077943 @default.
• W3003622489 creator A5004895861 @default.
• W3003622489 creator A5024413040 @default.
• W3003622489 creator A5024635734 @default.
• W3003622489 creator A5026837875 @default.
• W3003622489 creator A5028741505 @default.
• W3003622489 creator A5046314074 @default.
• W3003622489 creator A5048616798 @default.
• W3003622489 creator A5049195179 @default.
• W3003622489 creator A5049708836 @default.
• W3003622489 creator A5062551859 @default.
• W3003622489 creator A5065602571 @default.
• W3003622489 creator A5079367979 @default.
• W3003622489 creator A5083462423 @default.
• W3003622489 date "2020-01-28" @default.
• W3003622489 modified "2023-10-17" @default.
• W3003622489 title "Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany" @default.
• W3003622489 cites W1924064069 @default.
• W3003622489 cites W1942296996 @default.
• W3003622489 cites W1965800980 @default.
• W3003622489 cites W1969209267 @default.
• W3003622489 cites W1977565591 @default.
• W3003622489 cites W1994714113 @default.
• W3003622489 cites W2004077269 @default.
• W3003622489 cites W2013359164 @default.
• W3003622489 cites W2030685032 @default.
• W3003622489 cites W2044268151 @default.
• W3003622489 cites W2045940111 @default.
• W3003622489 cites W2051883261 @default.
• W3003622489 cites W2060553595 @default.
• W3003622489 cites W2062573090 @default.
• W3003622489 cites W2068694430 @default.
• W3003622489 cites W2090441982 @default.
• W3003622489 cites W2095256598 @default.
• W3003622489 cites W2098825592 @default.
• W3003622489 cites W2123412381 @default.
• W3003622489 cites W2124712956 @default.
• W3003622489 cites W2131462635 @default.
• W3003622489 cites W2132322340 @default.
• W3003622489 cites W2155063253 @default.
• W3003622489 cites W2407801685 @default.
• W3003622489 cites W2516716435 @default.
• W3003622489 cites W2725181561 @default.
• W3003622489 cites W2776280 @default.
• W3003622489 cites W2781860640 @default.
• W3003622489 cites W2791700605 @default.
• W3003622489 cites W2795575996 @default.
• W3003622489 cites W2886433380 @default.
• W3003622489 cites W2910330235 @default.
• W3003622489 cites W2948104235 @default.
• W3003622489 cites W2949088599 @default.
• W3003622489 cites W2956472870 @default.
• W3003622489 cites W2978085671 @default.
• W3003622489 cites W316595173 @default.
• W3003622489 cites W4231349503 @default.
• W3003622489 cites W4244644157 @default.
• W3003622489 cites W897554822 @default.
• W3003622489 doi "https://doi.org/10.1001/jama.2019.21565" @default.
• W3003622489 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6990943" @default.
• W3003622489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31990315" @default.
• W3003622489 hasPublicationYear "2020" @default.
• W3003622489 type Work @default.
• W3003622489 sameAs 3003622489 @default.
• W3003622489 citedByCount "118" @default.
• W3003622489 countsByYear W30036224892020 @default.
• W3003622489 countsByYear W30036224892021 @default.
• W3003622489 countsByYear W30036224892022 @default.
• W3003622489 countsByYear W30036224892023 @default.
• W3003622489 crossrefType "journal-article" @default.
• W3003622489 hasAuthorship W3003622489A5001077943 @default.
• W3003622489 hasAuthorship W3003622489A5004895861 @default.
• W3003622489 hasAuthorship W3003622489A5024413040 @default.
• W3003622489 hasAuthorship W3003622489A5024635734 @default.
• W3003622489 hasAuthorship W3003622489A5026837875 @default.
• W3003622489 hasAuthorship W3003622489A5028741505 @default.
• W3003622489 hasAuthorship W3003622489A5046314074 @default.
• W3003622489 hasAuthorship W3003622489A5048616798 @default.
• W3003622489 hasAuthorship W3003622489A5049195179 @default.
• W3003622489 hasAuthorship W3003622489A5049708836 @default.
• W3003622489 hasAuthorship W3003622489A5062551859 @default.
• W3003622489 hasAuthorship W3003622489A5065602571 @default.
• W3003622489 hasAuthorship W3003622489A5079367979 @default.
• W3003622489 hasAuthorship W3003622489A5083462423 @default.
• W3003622489 hasBestOaLocation W30036224891 @default.
• W3003622489 hasConcept C119060515 @default.
• W3003622489 hasConcept C126322002 @default.
• W3003622489 hasConcept C134018914 @default.
• W3003622489 hasConcept C139719470 @default.
• W3003622489 hasConcept C159654299 @default.
• W3003622489 hasConcept C162324750 @default.
• W3003622489 hasConcept C163764329 @default.
• W3003622489 hasConcept C187212893 @default.
• W3003622489 hasConcept C203014093 @default.
• W3003622489 hasConcept C2776867660 @default.
• W3003622489 hasConcept C2777180221 @default.
• W3003622489 hasConcept C2779306644 @default.

• next